MicroRNA‑143‑3p contributes to the regulation of pain responses in collagen‑induced arthritis

Zhou,Ling‑Ling; Zhu,Ya‑Mei; Qian,Fei‑Ya; Yuan,Cheng‑Chen; Yuan,Dong‑Ping; Zhou,Xue‑Ping

doi:10.3892/mmr.2018.9322

MicroRNA‑143‑3p contributes to the regulation of pain responses in collagen‑induced arthritis

Authors:
- Ling‑Ling Zhou
- Ya‑Mei Zhu
- Fei‑Ya Qian
- Cheng‑Chen Yuan
- Dong‑Ping Yuan
- Xue‑Ping Zhou
View Affiliations

Affiliations: School of Pharmacy, The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China
Published online on: July 26, 2018 https://doi.org/10.3892/mmr.2018.9322
Pages: 3219-3228
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with rheumatoid arthritis (RA) suffer from pain, which is associated with inflammation, peripheral and central pain processing, and joint structure damage. The aim of the present study was to investigate a key microRNA (miR) and its target genes that are involved in the pain responses of RA, and to clarify the mechanism of pain regulation. Collagen‑induced arthritis (CIA) was induced in DBA/1 and C57BL/6 mice. The paw swelling, mechanical withdrawal threshold (MWT), thermal withdrawal latency (TWL), and expression levels of tumor necrosis factor (TNF)‑α and prostaglandin (PG)E2 in the sera were investigated. Decreased MWT and TWL, and increased TNF‑α and PGE2, in the CIA model group were observed in DBA/1 and C57BL/6 mice. DBA/1 mice exhibited greater hyperalgesia and higher levels of inflammatory mediators. miR‑143‑3p expression in the blood and the dorsal root ganglion (DRG) were detected, and low miR‑143‑3p expression was demonstrated in the blood and DRG tissue of CIA mice. The target genes of miR‑143 were predicted and analyzed. A total of 1,305 genes were predicted and 55 pain‑associated genes were obtained. Prostaglandin‑endoperoxide synthase 2 (Ptgs2), MAS related GPR family member E (Mrgpre), prostaglandin D2 receptor and Tnf were selected as target genes of miR‑143. DRG cells were cultured and transfected with miR‑143‑3p inhibitor or mimic. The expression of Mrgpre, Ptgs2 and Tnf was significantly inhibited following miR‑143‑3p mimic transfection, while the expression of Mrgpre, Ptgs2 and Tnf was increased following inhibitor transfection. Additionally, the expression of pain‑associated genes in the DRG of mice was investigated and the expression of Ptgs2, Mrgpre and Tnf in the DRG of CIA mice was also significantly upregulated. These results revealed that CIA mice exhibited marked hyperalgesia and high levels of inflammatory pain mediators. Low expression of miR‑143‑3p negatively regulated the pain‑associated target genes, including Mrgpre, Ptgs2 and Tnf, thereby affecting chronic inflammatory pain and neuropathic pain in RA.

View Figures

View References

1	Heiberg T and Kvien TK: Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum. 47:391–397. 2002. View Article : Google Scholar : PubMed/NCBI
2	Walsh DA and Mcwilliams DF: Pain in rheumatoid arthritis. Curr Pain Headache Rep. 16:509–517. 2012. View Article : Google Scholar : PubMed/NCBI
3	Mcwilliams DF, Zhang W, Mansell JS, Kiely PD, Young A and Walsh DA: Predictors of change in bodily pain in early rheumatoid arthritis: An inception cohort study. Arthrit Care Res (Hoboken). 64:1505–1513. 2012. View Article : Google Scholar
4	Leffler AS, Kosek E, Lerndal T, Nordmark B and Hansson P: Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain. 6:161–176. 2002. View Article : Google Scholar : PubMed/NCBI
5	Gold MS and Gebhart GF: Nociceptor sensitization in pain pathogenesis. Nat Med. 16:1248–1257. 2010. View Article : Google Scholar : PubMed/NCBI
6	Bai G, Ambalavanar R, Wei D and Dessem D: Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain. 3:152007. View Article : Google Scholar : PubMed/NCBI
7	Aldrich BT, Frakes EP, Kasuya J, Hammond DL and Kitamoto T: Changes in expression of sensoryorgan-specific microRNAs in rat dorsal root ganglia in association with mechanical hypersensitivity induced by spinal nerve ligation. Neuroscience. 164:711–723. 2009. View Article : Google Scholar : PubMed/NCBI
8	Zhao J, Lee MC, Momin A, Cendan CM, Shepherd ST, Baker MD, Asante C, Bee L, Bethry A, Perkins JR, et al: Small RNAs control sodium channel expression, nociceptor excitability, and pain thresholds. J Neurosci. 30:10860–10871. 2010. View Article : Google Scholar : PubMed/NCBI
9	Zhu YM, Zhou LL, Peng XW, Geng S and Zhou XP: Study of Qingluo Tongbi Compound treating rheumatoid arthritis based on miRNA network. Chin J Immunol. 32:495–499. 2016.(In Chinese).
10	Yuan CC, Geng SA, Zhu YM, et al: Comparision of abnormal expression of miRNAsin peripheral blood of rheumatoid arthritis patients and osteoclasts in rat and analysis of MiRNAs. Chin J Immunol. 33:715–720. 2017.(In Chinese).
11	Cerdá-olmedo G, Mena-durán AV, Monsalve V and Oltra E: Identification of a MicroRNA Signature for the Diagnosis of Fibromyalgia. PLoS One. 10:e01219032015. View Article : Google Scholar : PubMed/NCBI
12	Pham H, Rodriguez CE, Donald GW, Hertzer KM, Jung XS, Chang HH, Moro A, Reber HA, Hines OJ and Eibl G: miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 439:6–11. 2013. View Article : Google Scholar : PubMed/NCBI
13	Tam Tam S, Bastian I, Zhou XF, Vander Hoek M, Michael MZ, Gibbins IL and Haberberger RV: MicroRNA-143 expression in dorsal root ganglion neurons. Cell Tissue Res. 346:163–173. 2011. View Article : Google Scholar : PubMed/NCBI
14	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. Publication no. 85-23 (rev.). 8th edition. The National Academies Press; 327. pp. 963–965. Washington, DC: 2011
15	Brand DD, Kang AH and Rosloniec EF: The mouse model of collagen-induced arthritis. Methods Mol Med. 102:295–312. 2004.PubMed/NCBI
16	Chaplan SR, Bach FW, Pogrel JW, Chung JM and Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth. 53:55–63. 1994. View Article : Google Scholar
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Schweinhardt P, Kalk N, Wartolowska K, Chessell I, Wordsworth P and Tracey I: Corrigendum to Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage. 56:3842011. View Article : Google Scholar
19	Billiau A and Matthys P: Collagen-induced arthritis and related animal models: How much of their pathogenesis is auto-immune, how much is auto-inflammatory. Cytokine Growth F R. 22:339–344. 2011. View Article : Google Scholar
20	Luross JA and Williams NA: The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology. 103:407–416. 2001. View Article : Google Scholar : PubMed/NCBI
21	Cook AD, Rowley MJ, Stockman A, Muirden KD and Mackay IR: Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol. 21:1186–1191. 1994.PubMed/NCBI
22	Walsh DA and Mcwilliams DF: Mechanisms, impact and management of pain in rheumatoid arthritis. Nat Rev Rheumatol. 10:581–592. 2014. View Article : Google Scholar : PubMed/NCBI
23	Junger H and Sorkin LS: Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain. 85:145–151. 2000. View Article : Google Scholar : PubMed/NCBI
24	Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M and Burge DJ: A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 340:253–259. 1999. View Article : Google Scholar : PubMed/NCBI
25	Boettger MK, Weber K, Grossmann D, Gajda M, Bauer R, Bär KJ, Schulz S, Voss A, Geis C, Bräuer R and Schaible HG: Spinal tumor necrosis factor α neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: A role for spinal tumor necrosis factor α during induction and maintenance of peripheral inflamma. Arthritis Rheum. 62:1308–1318. 2010. View Article : Google Scholar : PubMed/NCBI
26	Cox PJ, Pitcher T, Trim SA, Bell CH, Qin W and Kinloch RA: The effect of deletion of the orphan G- protein coupled receptor (GPCR) gene MrgE on pain-like behaviours in mice. Mol Pain. 4:22008. View Article : Google Scholar : PubMed/NCBI
27	Basbaum AI, Bautista DM, Scherrer G and Julius D: Cellular and molecular mechanisms of pain. Cell. 139:267–284. 2009. View Article : Google Scholar : PubMed/NCBI
28	Julius D and Basbaum AI: Molecular Mechanisms of nociception. Nature. 413:203–210. 2001. View Article : Google Scholar : PubMed/NCBI